| Apex Down River Behavioral Health | |
|
19366 Allen Rd Ste C Brownstown Twp MI 48183-6810 | |
| (734) 479-0949 | |
| Not Available |
| Full Name | Apex Down River Behavioral Health |
|---|---|
| Speciality | Social Worker |
| Location | 19366 Allen Rd Ste C, Brownstown Twp, Michigan |
| Authorized Official Name and Position | Thomas Johnson (CEO) |
| Authorized Official Contact | 7344790949 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Apex Down River Behavioral Health 19366 Allen Rd Ste C Brownstown Twp MI 48183-6810 Ph: (734) 479-0949 | Apex Down River Behavioral Health 19366 Allen Rd Ste C Brownstown Twp MI 48183-6810 Ph: (734) 479-0949 |
| NPI Number | 1922386952 |
|---|---|
| Provider Enumeration Date | 07/25/2011 |
| Last Update Date | 04/13/2012 |
| Medicare PECOS PAC ID | 2567623655 |
|---|---|
| Medicare Enrollment ID | O20120417000614 |
News Archive
A report of empirical sulphonylurea therapy in neonatal diabetes prior to genetic diagnosis highlights contrasting approaches to the problem.
Infants in special care baby units or neonatal intensive care units are at greater risk for missed or incomplete newborn screening than normal newborns. To minimize the risk of missing or delaying a diagnosis, Clinical and Laboratory Standards Institute (CLSI) recently published a new document, "Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline" (I/LA31-A).
The Sher Institutes of Reproductive Medicine (SIRM) announced today the introduction of the world's first CGH-Risk Sharing Plan that guarantees qualified IVF patients a baby or offers a full refund of the clinic's medical fees.
GeneTex, a leading manufacturer of high-quality antibodies, is pleased to announce that they will be launching EasyBlot, a new secondary antibody reagent that eliminates the interference that has long plagued immunoprecipitation (IP) experiments when the IP and western blot primary antibodies are from the same host.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922386952 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 6801011164 (Michigan) | Primary |
| Provider Name | James B Knowles |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1679513568 PECOS PAC ID: 5698748382 Enrollment ID: I20040819000909 |
News Archive
A report of empirical sulphonylurea therapy in neonatal diabetes prior to genetic diagnosis highlights contrasting approaches to the problem.
Infants in special care baby units or neonatal intensive care units are at greater risk for missed or incomplete newborn screening than normal newborns. To minimize the risk of missing or delaying a diagnosis, Clinical and Laboratory Standards Institute (CLSI) recently published a new document, "Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline" (I/LA31-A).
The Sher Institutes of Reproductive Medicine (SIRM) announced today the introduction of the world's first CGH-Risk Sharing Plan that guarantees qualified IVF patients a baby or offers a full refund of the clinic's medical fees.
GeneTex, a leading manufacturer of high-quality antibodies, is pleased to announce that they will be launching EasyBlot, a new secondary antibody reagent that eliminates the interference that has long plagued immunoprecipitation (IP) experiments when the IP and western blot primary antibodies are from the same host.
› Verified 9 days ago
| Provider Name | Harold E Joh |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1841264744 PECOS PAC ID: 5395631113 Enrollment ID: I20050803000584 |
News Archive
A report of empirical sulphonylurea therapy in neonatal diabetes prior to genetic diagnosis highlights contrasting approaches to the problem.
Infants in special care baby units or neonatal intensive care units are at greater risk for missed or incomplete newborn screening than normal newborns. To minimize the risk of missing or delaying a diagnosis, Clinical and Laboratory Standards Institute (CLSI) recently published a new document, "Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline" (I/LA31-A).
The Sher Institutes of Reproductive Medicine (SIRM) announced today the introduction of the world's first CGH-Risk Sharing Plan that guarantees qualified IVF patients a baby or offers a full refund of the clinic's medical fees.
GeneTex, a leading manufacturer of high-quality antibodies, is pleased to announce that they will be launching EasyBlot, a new secondary antibody reagent that eliminates the interference that has long plagued immunoprecipitation (IP) experiments when the IP and western blot primary antibodies are from the same host.
› Verified 9 days ago
| Provider Name | Karen D Joseph |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1497834717 PECOS PAC ID: 1153346556 Enrollment ID: I20051013000711 |
News Archive
A report of empirical sulphonylurea therapy in neonatal diabetes prior to genetic diagnosis highlights contrasting approaches to the problem.
Infants in special care baby units or neonatal intensive care units are at greater risk for missed or incomplete newborn screening than normal newborns. To minimize the risk of missing or delaying a diagnosis, Clinical and Laboratory Standards Institute (CLSI) recently published a new document, "Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline" (I/LA31-A).
The Sher Institutes of Reproductive Medicine (SIRM) announced today the introduction of the world's first CGH-Risk Sharing Plan that guarantees qualified IVF patients a baby or offers a full refund of the clinic's medical fees.
GeneTex, a leading manufacturer of high-quality antibodies, is pleased to announce that they will be launching EasyBlot, a new secondary antibody reagent that eliminates the interference that has long plagued immunoprecipitation (IP) experiments when the IP and western blot primary antibodies are from the same host.
› Verified 9 days ago
| Provider Name | Kenneth J Cunningham |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1831310697 PECOS PAC ID: 0547276511 Enrollment ID: I20060228000542 |
News Archive
A report of empirical sulphonylurea therapy in neonatal diabetes prior to genetic diagnosis highlights contrasting approaches to the problem.
Infants in special care baby units or neonatal intensive care units are at greater risk for missed or incomplete newborn screening than normal newborns. To minimize the risk of missing or delaying a diagnosis, Clinical and Laboratory Standards Institute (CLSI) recently published a new document, "Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline" (I/LA31-A).
The Sher Institutes of Reproductive Medicine (SIRM) announced today the introduction of the world's first CGH-Risk Sharing Plan that guarantees qualified IVF patients a baby or offers a full refund of the clinic's medical fees.
GeneTex, a leading manufacturer of high-quality antibodies, is pleased to announce that they will be launching EasyBlot, a new secondary antibody reagent that eliminates the interference that has long plagued immunoprecipitation (IP) experiments when the IP and western blot primary antibodies are from the same host.
› Verified 9 days ago
| Provider Name | Kelly R Smith |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1932399169 PECOS PAC ID: 1951495803 Enrollment ID: I20070921000836 |
News Archive
A report of empirical sulphonylurea therapy in neonatal diabetes prior to genetic diagnosis highlights contrasting approaches to the problem.
Infants in special care baby units or neonatal intensive care units are at greater risk for missed or incomplete newborn screening than normal newborns. To minimize the risk of missing or delaying a diagnosis, Clinical and Laboratory Standards Institute (CLSI) recently published a new document, "Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline" (I/LA31-A).
The Sher Institutes of Reproductive Medicine (SIRM) announced today the introduction of the world's first CGH-Risk Sharing Plan that guarantees qualified IVF patients a baby or offers a full refund of the clinic's medical fees.
GeneTex, a leading manufacturer of high-quality antibodies, is pleased to announce that they will be launching EasyBlot, a new secondary antibody reagent that eliminates the interference that has long plagued immunoprecipitation (IP) experiments when the IP and western blot primary antibodies are from the same host.
› Verified 9 days ago
| Provider Name | Gilbert W Pomeroy |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1114105426 PECOS PAC ID: 9032293444 Enrollment ID: I20080225000178 |
News Archive
A report of empirical sulphonylurea therapy in neonatal diabetes prior to genetic diagnosis highlights contrasting approaches to the problem.
Infants in special care baby units or neonatal intensive care units are at greater risk for missed or incomplete newborn screening than normal newborns. To minimize the risk of missing or delaying a diagnosis, Clinical and Laboratory Standards Institute (CLSI) recently published a new document, "Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline" (I/LA31-A).
The Sher Institutes of Reproductive Medicine (SIRM) announced today the introduction of the world's first CGH-Risk Sharing Plan that guarantees qualified IVF patients a baby or offers a full refund of the clinic's medical fees.
GeneTex, a leading manufacturer of high-quality antibodies, is pleased to announce that they will be launching EasyBlot, a new secondary antibody reagent that eliminates the interference that has long plagued immunoprecipitation (IP) experiments when the IP and western blot primary antibodies are from the same host.
› Verified 9 days ago
| Provider Name | Janis P Cox |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1578640280 PECOS PAC ID: 1658420070 Enrollment ID: I20090514000150 |
News Archive
A report of empirical sulphonylurea therapy in neonatal diabetes prior to genetic diagnosis highlights contrasting approaches to the problem.
Infants in special care baby units or neonatal intensive care units are at greater risk for missed or incomplete newborn screening than normal newborns. To minimize the risk of missing or delaying a diagnosis, Clinical and Laboratory Standards Institute (CLSI) recently published a new document, "Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline" (I/LA31-A).
The Sher Institutes of Reproductive Medicine (SIRM) announced today the introduction of the world's first CGH-Risk Sharing Plan that guarantees qualified IVF patients a baby or offers a full refund of the clinic's medical fees.
GeneTex, a leading manufacturer of high-quality antibodies, is pleased to announce that they will be launching EasyBlot, a new secondary antibody reagent that eliminates the interference that has long plagued immunoprecipitation (IP) experiments when the IP and western blot primary antibodies are from the same host.
› Verified 9 days ago
| Provider Name | Thomas E Johnson |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1639436173 PECOS PAC ID: 8325934136 Enrollment ID: I20120808000251 |
News Archive
A report of empirical sulphonylurea therapy in neonatal diabetes prior to genetic diagnosis highlights contrasting approaches to the problem.
Infants in special care baby units or neonatal intensive care units are at greater risk for missed or incomplete newborn screening than normal newborns. To minimize the risk of missing or delaying a diagnosis, Clinical and Laboratory Standards Institute (CLSI) recently published a new document, "Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline" (I/LA31-A).
The Sher Institutes of Reproductive Medicine (SIRM) announced today the introduction of the world's first CGH-Risk Sharing Plan that guarantees qualified IVF patients a baby or offers a full refund of the clinic's medical fees.
GeneTex, a leading manufacturer of high-quality antibodies, is pleased to announce that they will be launching EasyBlot, a new secondary antibody reagent that eliminates the interference that has long plagued immunoprecipitation (IP) experiments when the IP and western blot primary antibodies are from the same host.
› Verified 9 days ago
| Provider Name | Gary L Graham |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1992129704 PECOS PAC ID: 1456674852 Enrollment ID: I20141215002370 |
News Archive
A report of empirical sulphonylurea therapy in neonatal diabetes prior to genetic diagnosis highlights contrasting approaches to the problem.
Infants in special care baby units or neonatal intensive care units are at greater risk for missed or incomplete newborn screening than normal newborns. To minimize the risk of missing or delaying a diagnosis, Clinical and Laboratory Standards Institute (CLSI) recently published a new document, "Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline" (I/LA31-A).
The Sher Institutes of Reproductive Medicine (SIRM) announced today the introduction of the world's first CGH-Risk Sharing Plan that guarantees qualified IVF patients a baby or offers a full refund of the clinic's medical fees.
GeneTex, a leading manufacturer of high-quality antibodies, is pleased to announce that they will be launching EasyBlot, a new secondary antibody reagent that eliminates the interference that has long plagued immunoprecipitation (IP) experiments when the IP and western blot primary antibodies are from the same host.
› Verified 9 days ago
| Provider Name | Patricia Mary Milner |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1447541602 PECOS PAC ID: 6800103771 Enrollment ID: I20151007002613 |
News Archive
A report of empirical sulphonylurea therapy in neonatal diabetes prior to genetic diagnosis highlights contrasting approaches to the problem.
Infants in special care baby units or neonatal intensive care units are at greater risk for missed or incomplete newborn screening than normal newborns. To minimize the risk of missing or delaying a diagnosis, Clinical and Laboratory Standards Institute (CLSI) recently published a new document, "Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline" (I/LA31-A).
The Sher Institutes of Reproductive Medicine (SIRM) announced today the introduction of the world's first CGH-Risk Sharing Plan that guarantees qualified IVF patients a baby or offers a full refund of the clinic's medical fees.
GeneTex, a leading manufacturer of high-quality antibodies, is pleased to announce that they will be launching EasyBlot, a new secondary antibody reagent that eliminates the interference that has long plagued immunoprecipitation (IP) experiments when the IP and western blot primary antibodies are from the same host.
› Verified 9 days ago
| Provider Name | Michael Salinas |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336530252 PECOS PAC ID: 4688004690 Enrollment ID: I20200415000736 |
News Archive
A report of empirical sulphonylurea therapy in neonatal diabetes prior to genetic diagnosis highlights contrasting approaches to the problem.
Infants in special care baby units or neonatal intensive care units are at greater risk for missed or incomplete newborn screening than normal newborns. To minimize the risk of missing or delaying a diagnosis, Clinical and Laboratory Standards Institute (CLSI) recently published a new document, "Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline" (I/LA31-A).
The Sher Institutes of Reproductive Medicine (SIRM) announced today the introduction of the world's first CGH-Risk Sharing Plan that guarantees qualified IVF patients a baby or offers a full refund of the clinic's medical fees.
GeneTex, a leading manufacturer of high-quality antibodies, is pleased to announce that they will be launching EasyBlot, a new secondary antibody reagent that eliminates the interference that has long plagued immunoprecipitation (IP) experiments when the IP and western blot primary antibodies are from the same host.
› Verified 9 days ago
| Provider Name | Elizabeth I Yaklin |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1528381860 PECOS PAC ID: 0941617468 Enrollment ID: I20210330001818 |
News Archive
A report of empirical sulphonylurea therapy in neonatal diabetes prior to genetic diagnosis highlights contrasting approaches to the problem.
Infants in special care baby units or neonatal intensive care units are at greater risk for missed or incomplete newborn screening than normal newborns. To minimize the risk of missing or delaying a diagnosis, Clinical and Laboratory Standards Institute (CLSI) recently published a new document, "Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline" (I/LA31-A).
The Sher Institutes of Reproductive Medicine (SIRM) announced today the introduction of the world's first CGH-Risk Sharing Plan that guarantees qualified IVF patients a baby or offers a full refund of the clinic's medical fees.
GeneTex, a leading manufacturer of high-quality antibodies, is pleased to announce that they will be launching EasyBlot, a new secondary antibody reagent that eliminates the interference that has long plagued immunoprecipitation (IP) experiments when the IP and western blot primary antibodies are from the same host.
› Verified 9 days ago
| Provider Name | Timothy A Laurin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1700214665 PECOS PAC ID: 3274763040 Enrollment ID: I20211118001719 |
News Archive
A report of empirical sulphonylurea therapy in neonatal diabetes prior to genetic diagnosis highlights contrasting approaches to the problem.
Infants in special care baby units or neonatal intensive care units are at greater risk for missed or incomplete newborn screening than normal newborns. To minimize the risk of missing or delaying a diagnosis, Clinical and Laboratory Standards Institute (CLSI) recently published a new document, "Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline" (I/LA31-A).
The Sher Institutes of Reproductive Medicine (SIRM) announced today the introduction of the world's first CGH-Risk Sharing Plan that guarantees qualified IVF patients a baby or offers a full refund of the clinic's medical fees.
GeneTex, a leading manufacturer of high-quality antibodies, is pleased to announce that they will be launching EasyBlot, a new secondary antibody reagent that eliminates the interference that has long plagued immunoprecipitation (IP) experiments when the IP and western blot primary antibodies are from the same host.
› Verified 9 days ago
News Archive
A report of empirical sulphonylurea therapy in neonatal diabetes prior to genetic diagnosis highlights contrasting approaches to the problem.
Infants in special care baby units or neonatal intensive care units are at greater risk for missed or incomplete newborn screening than normal newborns. To minimize the risk of missing or delaying a diagnosis, Clinical and Laboratory Standards Institute (CLSI) recently published a new document, "Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline" (I/LA31-A).
The Sher Institutes of Reproductive Medicine (SIRM) announced today the introduction of the world's first CGH-Risk Sharing Plan that guarantees qualified IVF patients a baby or offers a full refund of the clinic's medical fees.
GeneTex, a leading manufacturer of high-quality antibodies, is pleased to announce that they will be launching EasyBlot, a new secondary antibody reagent that eliminates the interference that has long plagued immunoprecipitation (IP) experiments when the IP and western blot primary antibodies are from the same host.
› Verified 9 days ago
Apex Behavioral Health, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 19366 Allen Rd, Suite C, Brownstown Twp, MI 48183 Phone: 734-479-0949 Fax: 734-479-1637 | |
Empowerment Counseling Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 23772 West Rd # 113, Brownstown Twp, MI 48183 Phone: 734-626-7648 | |
Apex Downriver Behavioral Health Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 19366 Allen Rd Ste C, Brownstown Twp, MI 48183 Phone: 734-479-0949 | |
Integrative Pediatric Therapy Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 19117 Allen Rd Ste C, Brownstown Twp, MI 48183 Phone: 734-720-7694 |